A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
Ketamine has gained rapid popularity as a treatment option for treatment resistant depression (TRD). Though seen only in limited contexts, ketamine is a potential drug of abuse, addiction and diversion. Clinical ketamine studies to date have not systematically evaluated factors relevant to addiction...
Main Authors: | Brittany Chubbs, Jay Wang, Shaina Archer, Carson Chrenek, Atul Khullar, Michael Wolowyk, Jennifer Swainson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1016439/full |
Similar Items
-
Safety, effectiveness and tolerability of sublingual ketamine in depression and anxiety: A retrospective study of off-label, at-home use
by: Kazi Hassan, et al.
Published: (2022-09-01) -
The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine
by: Jay Wang, et al.
Published: (2022-03-01) -
Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety
by: Johannes Hauser, et al.
Published: (2024-01-01) -
Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders
by: Glenn Hartelius, et al.
Published: (2023-08-01) -
Comparison of the effectiveness of intranasal ketamine compared with intravenous ketamine in controlling pain during cataract surgery
by: Hamidreza Shetabi, et al.
Published: (2022-11-01)